甲状腺功能亢进症患者治疗后骨密度的评估
郑小宇
【期刊名称】《中国医药指南》 【年(卷),期】2013(000)018
【摘要】Objective To study the changed condition of bone mineral density after treatment for patients with hyperthyroidism. Methods Choosed 40 patients with hyperthyroidism from Sep. 2011 to Jun. 2012 to determine their bone mineral density (BMD) before and after 3 months and 6 months treatment. Compared the data. Results The BMD before treatment was (0.761±0.254)g/cm, and (0.976±0.143)g/cm2 after 3 months treatment, and(1.077± 0.331)g/cm2 after 6 months treatment. And there was significant difference after 6 months treatment (P<0.05). Conclusion We could improve osteoporosis of patients with hyperthyroidism for treatment in a period.% 目的探讨分析甲状腺功能亢进症患在接受药物治疗前后骨密度的改变情况，供临床参考使用。方法随机抽取我院2011年9月至2012年6月间内分泌科收治的初次诊断甲状腺功能亢进症患者40例，在治疗前以及给予相应抗甲状腺药物治疗3个月、6个月后分别测定其骨密度，治疗前后数据进行统计学分析。结果本组40例患者治疗6个月后，在 TT4、TT3、FT4以及 FT3几项指标上，均出现明显改善（P ＜0.05）；本组40例患者未予任何治疗前骨密度值为（0.761±0.254）g/cm2，治疗3个月后为（0.976±0.143）g/cm2，治疗6个月后为（1.077±0.331）g/cm2；与治疗前相比计较，治疗3个月后改变无统计学意义（P ＞0.05），治
甲状腺功能亢进症患者治疗后骨密度的评估
